SU‐GG‐J‐73: Dose Distribution Improvements for Prostate Cancer Patients Using Hybrid Image Guidance Systems
Purpose: Daily setup variations may compromise the precision of dose delivery, tumorcontrol and normal tissue avoidance. This study analyzed the setup variations predicted by kilo‐voltage Cone Beam CT(CBCT) combined with 3D Ultrasoundimage guidance. The overall integrity of prostate dose distribution was considered to define an offset threshold above which image guidance becomes crucial for dose delivery. Method and Materials: Initial immobilization was performed using three‐point in‐room lasers. The residual positional errors were assessed using CBCT from Varian Trilogy™ and Ultrasound guidance by Sonarray™ system. Superposition of offset vectors on the initial prostate plans enabled detailed evaluation of resultant changes in dosimetric and biological aspects for target and organs at risk. On‐line CBCTimages were used for calculation. Dose volume histograms (DVH), Gamma Index (GI), equivalent uniform dose (EUD) and tumorcontrol probability (TCP) were calculated. Other indices such as mean total dose (mTd) and maximal total dose (MTD) for normal structures were also considered in defining the threshold. Results and Conclusion: After initial laser alignment, the mean vector of residual displacements over all prostate patients is 6.2mm with a 5.0mm standard deviation. The decrease in EUD for defined tumor volumes was up to 66% when the largest offset was applied and 10% in the composite plan which incorporated overall offset histories. Results show that if patient's offsets were smaller than the applied PTV margin (5mm), unappreciable changes in dose coverage and tumorcontrol were revealed. However, if offsets were larger than the PTV margin, tumorcontrol and normal tissue sparing can be significantly compromised if proper couch shifts are not made under the imaging guidance system. In this situation, special attention is needed especially on organs at risk and even the adaptive radiotherapy might be necessary.